Immutep Limited (IMMP)
NASDAQ·Healthcare·Biotechnology
$0.37
+3.29%
Mkt Cap $406.25M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$4.25
Range $3.50 – $5.00
Implied Upside
+1039.4%
Consensus $4.25 vs current $0.37
NASDAQ·Healthcare·Biotechnology
$0.37
+3.29%
Mkt Cap $406.25M
No recent rating data.
Price Target (3 analysts)
$4.25
Range $3.50 – $5.00
+1039.4%
Consensus $4.25 vs current $0.37